中华内分泌外科杂志2024,Vol.18Issue(1) :94-98.DOI:10.3760/cma.j.cn.115807-20231204-00180

125I放射性粒子植入保肛治疗低位直肠癌临床分析

Interstitial implantation of 125I radioactive seeds for low rectal cancer with anal sphincter preservation

陶有茂 吕金强 盖保东
中华内分泌外科杂志2024,Vol.18Issue(1) :94-98.DOI:10.3760/cma.j.cn.115807-20231204-00180

125I放射性粒子植入保肛治疗低位直肠癌临床分析

Interstitial implantation of 125I radioactive seeds for low rectal cancer with anal sphincter preservation

陶有茂 1吕金强 1盖保东1
扫码查看

作者信息

  • 1. 吉林大学中日联谊医院胃肠结直肠肛门外科,长春 130033
  • 折叠

摘要

目的 评价125I放射性粒子植入保肛治疗不能耐受直肠癌根治术的低位直肠癌的安全性和可行性.方法 回顾分析放射性粒子植入保肛治疗的8例经病理证实的不能或不愿接受直肠癌根治术的低位直肠癌患者的临床资料.结果 8例低位直肠癌患者在超声引导下顺利安全地完成125I放射性粒子植入手术,术前表现的黏液脓血便、会阴部疼痛、肛门下坠感、排便不净感等临床症状均显著改善,术后患者CEA水平均显著下降.4例复查肠镜、CT见肿瘤消失,所有患者均成功保留肛门功能.术后平均生存时间为32.4个月.结论 放射性粒子植入保肛治疗低位直肠癌可有效提高患者的生活质量.

Abstract

Objective To assess the effectiveness and characteristics of intratumoral radioactive seed im-plantation in low rectal cancer with anal sphincter preservation.Methods Clinical data of 8 patients(not willing or can not to undergo radical resection of rectal carcinoma)with low rectal cancer receiving radioactive seed implan-tation with anal sphincter preservation were retrospectively analyzed.Results All the 8 patients successfully com-pleted intratumoral radioactive seed implantation.Preoperative clinical symptoms of discomfort were significantly improved,and CEA levels decreased significantly.Colonoscopy and CT examination showed that tumor disap-peared in 4 cases,anal function was successfully preserved in all patients.The mean survival time was 32.4 months.Conclusions Intratumoral radioactive seed implantation in low rectal cancer with anal sphincter preser-vation can effectively improve the quality of life of patients.

关键词

低位直肠癌/放射性粒子/保肛手术

Key words

Low rectal cancer/Radioactive seeds/Anal preservation surgery

引用本文复制引用

出版年

2024
中华内分泌外科杂志
中华医学会

中华内分泌外科杂志

CSTPCD
影响因子:0.657
ISSN:1674-6090
参考文献量14
段落导航相关论文